good sense naproxen sodium NDC 0113-8264

Product information

Brand name (proprietary)

good sense naproxen sodium

Generic name (nonproprietary)

diphenhydramine hydrochloride, naproxen sodium

Active ingredients

Diphenhydramine hydrochloride — 25 mg/1Naproxen sodium — 220 mg/1

Dosage form

Tablet, Film coated

Route

Oral

Labeler

L. Perrigo Company

Product type

Over-the-counter drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 208499

Marketing start

Dec 28, 2018

Listing expires

Dec 31, 2027

Other FDA classes

Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)Histamine H1 Receptor Antagonists (Mechanism)

Identifiers

Product ID 0113-8264_2d70302c-e43d-4422-a002-57505904f605SPL ID 2d70302c-e43d-4422-a002-57505904f605SPL set ID f548aa3d-b35e-458a-9815-3595a451ab78RxCUI 1550957UNII TC2D6JAD40, 9TN87S3A3C

Pharmacologic class

Histamine-1 Receptor Antagonist; Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400113826406 followed by a unit qualifier and the quantity Copy

Package 00113-8264-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 208499

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.